The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn's disease.
Proinflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha) might be, at least partially, responsible for the development of osteopenia or osteoporosis in Crohn's disease. We investigated whether anti-TNF therapy for Crohn's disease could have any skeletal impact. Therefor...
Main Authors: | , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|